pentylenetetrazole has been researched along with finasteride in 11 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (9.09) | 18.2507 |
2000's | 8 (72.73) | 29.6817 |
2010's | 1 (9.09) | 24.3611 |
2020's | 1 (9.09) | 2.80 |
Authors | Studies |
---|---|
Banks, MK; Kokate, TG; Magee, T; Rogawski, MA; Yamaguchi, S | 1 |
Reddy, DS; Rogawski, MA | 2 |
Kim, HY; Reddy, DS; Rogawski, MA | 1 |
Reddy, DS | 1 |
Frye, CA; Rhodes, ME | 1 |
Burnham, WM; Edwards, HE; Vimal, S | 1 |
Burnham, WM; Likhodii, S; Perez-Cruz, C | 1 |
Beadles-Bohling, AS; Crabbe, JC; Finn, DA; Ford, MM; Gililland-Kaufman, KR; Mark, GP; Snelling, C; Tanchuck, MA | 1 |
Dhir, A; Rogawski, MA | 1 |
Dhillon, HK; Goel, RK; Singh, T | 1 |
11 other study(ies) available for pentylenetetrazole and finasteride
Article | Year |
---|---|
Finasteride, a 5alpha-reductase inhibitor, blocks the anticonvulsant activity of progesterone in mice.
Topics: Animals; Anticonvulsants; Cholestenone 5 alpha-Reductase; Convulsants; Drug Interactions; Electroshock; Enzyme Inhibitors; Finasteride; Isoenzymes; Male; Mice; Oxidoreductases; Pentylenetetrazole; Pregnanolone; Progesterone; Seizures | 1999 |
Enhanced anticonvulsant activity of ganaxolone after neurosteroid withdrawal in a rat model of catamenial epilepsy.
Topics: Animals; Anticonvulsants; Convulsants; Diazepam; Disease Models, Animal; Enzyme Inhibitors; Epilepsy; Female; Finasteride; Menstruation; Oxidoreductases; Pentylenetetrazole; Pregnanolone; Pseudopregnancy; Rats; Rats, Sprague-Dawley; Seizures; Steroids; Valproic Acid | 2000 |
Neurosteroid withdrawal model of perimenstrual catamenial epilepsy.
Topics: 20-alpha-Dihydroprogesterone; Adult; Animals; Behavior, Animal; Disease Models, Animal; Disease Susceptibility; Epilepsy; Female; Finasteride; Gonadotropins, Equine; Humans; Menstrual Cycle; Pentylenetetrazole; Pregnanolone; Progesterone; Pseudopregnancy; Rats; Rats, Sprague-Dawley; Receptors, GABA; Steroids; Substance Withdrawal Syndrome | 2001 |
Stress-induced deoxycorticosterone-derived neurosteroids modulate GABA(A) receptor function and seizure susceptibility.
Topics: 5-alpha Reductase Inhibitors; Adrenalectomy; Animals; Anti-Inflammatory Agents, Non-Steroidal; Convulsants; Corticosterone; Desoxycorticosterone; Disease Susceptibility; Dose-Response Relationship, Drug; Drug Antagonism; Drug Resistance; Enzyme Inhibitors; Exercise Test; Finasteride; Indomethacin; Kindling, Neurologic; Male; Mice; Motor Activity; Pentylenetetrazole; Rats; Rats, Sprague-Dawley; Receptors, GABA-A; Seizures; Steroids; Stress, Physiological | 2002 |
Testosterone modulation of seizure susceptibility is mediated by neurosteroids 3alpha-androstanediol and 17beta-estradiol.
Topics: Androstane-3,17-diol; Animals; Aromatase Inhibitors; Chromatography; Convulsants; Dose-Response Relationship, Drug; Enzyme Inhibitors; Estradiol; Finasteride; Hippocampus; Letrozole; Male; Mass Spectrometry; Mice; Nitriles; Organ Culture Techniques; Patch-Clamp Techniques; Pentylenetetrazole; Rats; Receptors, GABA-A; Seizures; Testosterone; Triazoles | 2004 |
Attenuating 5alpha-pregnane-3alpha-ol-20-one formation in the hippocampus of female rats increases pentylenetetrazole-induced seizures.
Topics: Animals; Behavior, Animal; Desoxycorticosterone; Dose-Response Relationship, Drug; Drug Administration Routes; Drug Interactions; Enzyme Inhibitors; Female; Finasteride; Hippocampus; Ovariectomy; Pentylenetetrazole; Progesterone; Radioimmunoassay; Rats; Rats, Long-Evans; Seizures | 2005 |
The acute anticonvulsant effects of deoxycorticosterone in developing rats: role of metabolites and mineralocorticoid-receptor responses.
Topics: Animals; Animals, Newborn; Anticonvulsants; Desoxycorticosterone; Disease Models, Animal; Enzyme Inhibitors; Finasteride; Mineralocorticoid Receptor Antagonists; Pentylenetetrazole; Rats; Receptors, GABA; Receptors, Mineralocorticoid; Receptors, Progesterone; Seizures; Spironolactone | 2005 |
Deoxycorticosterone's anticonvulsant effects in infant rats are blocked by finasteride, but not by indomethacin.
Topics: Animals; Animals, Newborn; Anticonvulsants; Desoxycorticosterone; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Enzyme Inhibitors; Epilepsy, Tonic-Clonic; Finasteride; Indomethacin; Male; Pentylenetetrazole; Rats; Rats, Sprague-Dawley; Time Factors | 2006 |
The neurosteroid environment in the hippocampus exerts bi-directional effects on seizure susceptibility in mice.
Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; 5-alpha Reductase Inhibitors; Alcohol-Induced Disorders, Nervous System; Animals; Anticonvulsants; Convulsants; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme Inhibitors; Epilepsy; Finasteride; Genetic Predisposition to Disease; Hippocampus; Mice; Mice, Transgenic; Neurons; Pentylenetetrazole; Pregnanolone; Substance Withdrawal Syndrome | 2008 |
Role of neurosteroids in the anticonvulsant activity of midazolam.
Topics: 5-alpha Reductase Inhibitors; Animals; Anticonvulsants; Clonazepam; Convulsants; Disease Models, Animal; Finasteride; GABA Antagonists; Isoquinolines; Male; Mice; Midazolam; Neurotransmitter Agents; Pentylenetetrazole; Receptors, GABA; Seizures | 2012 |
Ferulic acid inhibits catamenial epilepsy through modulation of female hormones.
Topics: Adult; Animals; Corticosterone; Epilepsy; Estradiol; Female; Finasteride; Horses; Humans; Mice; Neurosteroids; Pentylenetetrazole; Progesterone; Seizures | 2022 |